| 2025-04-02 | -0.69 % |
|
| 2025-03-31 | -0.14 % |
|
| 2025-03-28 | +2.33 % |
|
| 2025-03-27 | +0.05 % |
|
| 2025-03-24 | +2.27 % |
|
| 2025-03-21 | -0.93 % |
|
| 2025-03-20 | -0.58 % |
|
| 2025-03-19 | -0.81 % |
|
| 2025-03-12 | +0.06 % |
|
| 2025-03-11 | +0.75 % |
|
| 2025-03-10 | -0.85 % |
|
| 2025-03-06 | -3.8 % |
|
| 2025-03-04 | -1.89 % |
|
| 2025-02-27 | +0.58 % |
|
| 2025-02-24 | +1.39 % |
|
| 2025-02-18 | +0.55 % |
|
| 2025-02-13 | +3.37 % |
|
| 2025-02-05 | +2.4 % |
|
| 2025-01-31 | -0.51 % |
|
| 2025-01-30 | +1.67 % |
|
| 2025-01-27 | +1.24 % |
|
| 2025-01-23 | +0.83 % |
|
| 2025-01-22 | -1.89 % |
|
| 2025-01-15 | -0.22 % |
|
| 2025-01-14 | +0.91 % |
|
| 2025-01-13 | +0.75 % |
|
| 2025-01-07 | +0.15 % |
|
| 2025-01-06 | -1.41 % |
|
| 2025-01-02 | -1.04 % |
|
| 2024-12-30 | -0.06 % |
|
| 2024-12-26 | -0.16 % |
|
| 2024-12-23 | +0.79 % |
|
| 2024-12-09 | -1.46 % |
|
| 2024-12-04 | +0.56 % |
|
| 2024-12-03 | -0.88 % |
|
| 2024-12-02 | -3 % |
|
| 2024-11-21 | +0.35 % |
|
| 2024-11-12 | -1.21 % |
|
| 2024-11-04 | +0.78 % |
- Welltower Inc. (NYSE: WELL) stock rose 0.78% as institutional investors have shown mixed investment activity, with some increasing their stakes following strong revenue growth, positive analyst ratings, and the upcoming dividend announcement despite a miss in earnings per share.
The increase in Welltower's stock price is likely attributed to its strong revenue growth of 23.7% year-over-year, positive analyst outlooks, and the dividends being distributed, which suggest confidence in the company's financial stability.
- Welltower (WELL) stock rose 0.78% amid a broader market decline, possibly due to investor sentiment favoring REITs in the current economic climate, alongside expectations of improved performance in the healthcare sector.
- Welltower Inc. (NYSE: WELL) stock rose by 0.78% potentially due to institutional investments, including a new stake from Focus Financial Network and increased positions from Vanguard Group and Capital International, alongside positive revenue growth and valuation upgrades by equity analysts.
- Welltower (WELL) stock rose by 0.78% following Jack Nathan Medical Corp's announcement of a significant asset sale to WELL for Cdn$5,000,000, which is expected to strengthen WELL’s position in the healthcare sector and enhance its financial stability by eliminating a large portion of Jack Nathan's debt.
- Welltower (WELL) stock increased by 0.78% due to positive investor sentiment amid broader market fluctuations and the underlying strength of the healthcare real estate sector in current economic conditions.
|
| 2024-10-31 | -2.58 % |
|
| 2024-10-30 | +0.81 % |
|
| 2024-10-29 | +5.18 % |
- Welltower Inc. (WELL) stock rose 5.18% likely due to positive earnings performance, with reported earnings per share surpassing expectations and analysts raising their price targets and upgrade ratings for the stock, reflecting growing investor confidence.
- Welltower (WELL) stock rose 5.18% following a strong third-quarter earnings report, where the company achieved record revenue of over $2 billion, reported a 23% increase in net operating income for its senior housing portfolio, raised its full-year cash flow guidance, and completed $2.2 billion in acquisitions, indicating robust growth and positive momentum in the senior housing market.
Welltower's stock increase can be attributed to its strong financial performance, including significant revenue growth, increased occupancy rates, and successful acquisitions, coupled with favorable market trends in senior housing demographics.
- Welltower (NYSE:WELL) stock rose by 5.18% following a dividend announcement, indicating positive investor sentiment likely driven by the appeal of dividends as a source of income amidst current market conditions.
- Welltower Inc. (NYSE: WELL) experienced a 5.18% increase in stock price following significant institutional investment and positive analyst upgrades that boosted the company's price targets and overall market sentiment.
- Welltower Inc. (WELL) stock rose by 5.18% due to positive analyst ratings and price target increases, along with significant institutional investment activity, suggesting strong investor confidence in the company's performance and future prospects.
|
| 2024-10-28 | +0.28 % |
|
| 2024-10-24 | +0.2 % |
|
| 2024-10-22 | +0.02 % |
|
| 2024-10-18 | +1.15 % |
|
| 2024-10-16 | +0.85 % |
|
| 2024-10-15 | +1.29 % |
|
| 2024-10-14 | +1.93 % |
|
| 2024-10-11 | +1.68 % |
|
| 2024-10-10 | -0.99 % |
|
| 2024-10-07 | -1.03 % |
|
| 2024-10-04 | -0.71 % |
|
